Search results for: 'biologics industry'

The global energy industry is going through an unprecedented transition period, and this change is bringing exciting new growth opportunities to the oil and gas (O&G) sector. However, the shift to a net-zero future for carbon emissions means many companies are also facing pricing, energy security, and industry disruption struggles. The energy indus...

The Sri Lankan government’s commitment to the healthcare and education sectors is commendable. However, the demographic and epidemiological transformation is urging for reforming the primary healthcare delivery model of the country. Non-communicable diseases are on the rise and account for 85% of deaths in the country. The quality of healthcare ser...

Frost & Sullivan provides comprehensive insights into the global biologics contract development and manufacturing organization (bio-CDMO) market, including emerging trends, growth opportunities, and profiles of leading bio-CDMOs and their business model evolution. The growth of next-generation biologics and personalized therapies and the emergence ...

24 Jul 2020  |  North America  |  Market Research

Curative Oncology and Rare Disease Therapies Transforming the Global Biologics Market, 2020–2024

Strategic Collaborations with Specialty Bio-CDMOs will Continue to Drive Growth Opportunities in Antibody-drug Conjugates and Gene Therapies

Infographics

×

Key Issues Addressed

With this research service, Frost & Sullivans Transformational Health team provides critical insights into the global biologics industry highlighting the growth opportunities, market revenue segmentation, and technology trends influencing its growth. The global biologics market covered in this study includes 4 major segments – antibody therapies, r...

This study assesses the automotive market in China, focusing on the passenger vehicle (PV) market. Within this, Frost & Sullivan will also discuss electric vehicles (EVs), charging, and battery swapping. China’s automotive market has proliferated, particularly after the 2008 Beijing Olympics. The unit shipment of China’s PV market has consiste...

The Future of the United States explores the transformative trends shaping national competitiveness, economic resilience, and technological leadership through 2035. US energy policy is reinforcing fossil fuel expansion while navigating the growth of renewables, addressing increasing electricity demand from AI-intensive industries, and modernizing t...

The United States is undergoing a dramatic transformation across technology, finance, and industrial sectors, driven by increased innovation, investment, and consumer interest in advanced technologies. Artificial intelligence (AI), smart homes, the Internet of Things (IoT), and the metaverse are among the mainstream applications at the forefront of...

17 Jun 2021  |  North America  |  Market Research

Global Biologics Contract Development and Manufacturing Organizations Growth Opportunities

Asset Co-Development with Clinical-stage Biopharmaceutical Companies and Disruptive Technologies Present Future Growth Potential

Infographics

×

This study presents Frost & Sullivans overall market and segment-wise revenue forecasts of the global biologics contract development and manufacturing organizations (bio-CDMO) market. It also highlights key growth opportunities for bio-CDMO market participants based on the main evolution in their business models and strategic approaches, as well as...

This research service covers the U.S. rheumatoid arthritis (RA) market from 2007 to 2017, with 2010 as the base year. Included in this research service are products currently in the market, products in development, and patient forecasts. Market challenges, drivers, and restraints are identified and assessed. Strategic recommendations are presented ...